CZC-54252

CAS No. 1191911-27-9

CZC-54252( CZC-54252 | CZC 54252 | CZC54252 )

Catalog No. M10659 CAS No. 1191911-27-9

CZC-54252 is a potent inhibitor of LRRK2 with IC50s of 1.28 nM and 1.85 nM for wild-type and G2019S LRRK2 respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 124 In Stock
25MG 210 In Stock
50MG 311 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CZC-54252
  • Note
    Research use only, not for human use.
  • Brief Description
    CZC-54252 is a potent inhibitor of LRRK2 with IC50s of 1.28 nM and 1.85 nM for wild-type and G2019S LRRK2 respectively.
  • Description
    CZC-54252 is a potent inhibitor of LRRK2 with IC50s of 1.28 nM and 1.85 nM for wild-type and G2019S LRRK2 respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CZC-54252 | CZC 54252 | CZC54252
  • Pathway
    Autophagy
  • Target
    LRRK2
  • Recptor
    LRRK2
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1191911-27-9
  • Formula Weight
    504.39
  • Molecular Formula
    C22H25ClN6O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 100 mM
  • SMILES
    CS(=O)(NC1=CC=CC=C1NC2=NC(NC3=CC=C(N4CCOCC4)C=C3OC)=NC=C2Cl)=O
  • Chemical Name
    N-(2-((5-chloro-2-((2-methoxy-4-morpholinophenyl)amino)pyrimidin-4-yl)amino)phenyl)methanesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Liu F, et al. J Pharmacol Exp Ther, 2008, 327(3), 827-839.
molnova catalog
related products
  • GNE-7915 tosylate

    GNE-7915 tosylate (GNE7915 tosylate) is a highly potent, selective, and brain-penetrable LRRK2 inhibitor with IC50 of 1.9 nM.

  • PF-06454589

    PF-06454589 is a potent inhibitor of LRRK2.

  • LRRK2-IN-1

    A potent LRRK2 inhibitor with IC50s of 13 nM/6 nM for wild-type/G2019S mutant LRRK2 repectively (0.1 mM ATP in the assay).